Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

truthseeeker Sep. 7 at 2:33 PM

$PFE read a well balanced article from simply wall st that stated that PFE is fully valued currently. That means the price already reflects potential good and has little to no upside from here , perhaps some modest downside. conclusion , at best a hold, definitely not a buy at these levels...............

0 · Reply

MollyJones567 Sep. 6 at 8:24 PM

$PFE volume really picking up here, way above the average pace today. Something's brewing under the surface. Bulls stepping in with size. Watching this one closely into the close.

0 · Reply

Noobnr1 Sep. 6 at 5:30 AM

$NYXH Hello we are so underrated, helping lots of people for a better sleep. Going to be a huge business, expanding well $GILD $PFE $OMER

0 · Reply

taxplanr Sep. 6 at 2:59 AM

13 year old football player dies at practice from cardiac arrest $MRNA $PFE $BNTX https://www.tiktok.com/t/ZTU6oeDBJ/

0 · Reply

IntiTheSunGod Sep. 5 at 8:04 PM

$IMRN will $PFE be the interested partner for IMM-529? Currently, they’re in phase 3 clinical trials with Vanderbilt University for another C. difficile medication

0 · Reply

EingeLTrade Sep. 5 at 6:07 PM

$PFE

0 · Reply

KimberleyAnn Sep. 5 at 11:57 AM

$MDCX $PFE mdcx, took a handful on this news; and watching walf’s calls over the summer have been pretty 🥵

0 · Reply

Agent8 Sep. 5 at 8:00 AM

$PFE I personally hope this gets approved knowing the dangers and effects of tick borne Lyme disease. 🤞https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-valnevas-lyme-disease-vaccine-candidate LT

0 · Reply

Duskfall Sep. 5 at 4:26 AM

$MDCX The current market capitalization of approximately $11 million is very low relative to what the company currently has in its pipeline. Keep👀📈✅ 🔥🔥🔥🔥🔥 $OCGN $PFE $MRNA $SPY

0 · Reply

walfofwallstreet Sep. 4 at 11:57 PM

$MDCX $1 billion deal with $PFE 💎 💯% candidate Tuesday 🤫

1 · Reply

Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer

PCVX TEVA

Sep 2, 2026, 9:00 AM EDT - 5 days ago

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

XRAY

Aug 31, 2026, 1:20 PM EDT - 7 days ago

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

LLY NVO TAK

Aug 31, 2026, 12:09 PM EDT - 7 days ago

Trump administration to announce drug pricing deals

AMGN LLY TAK

Aug 27, 2026, 5:48 PM EDT - 10 days ago

US FDA approves updated COVID vaccines for 2026-27 season

MRNA NVAX SNY BNTX

2026-08-27T20:35:15.000Z - 10 days ago

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

BNTX

Aug 27, 2026, 4:30 PM EDT - 10 days ago

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

BNTX

Aug 26, 2026, 12:48 PM EDT - 12 days ago

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

AMGN LLY

2026-08-24T12:18:00.000Z - 14 days ago

Pfizer Stock (PFE) Is a Buy despite Declining Revenue

2026-08-19T14:35:12.000Z - 19 days ago

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

BNTX MRK MRNA

2026-08-16T13:55:21.000Z - 22 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

2026-08-14T18:45:04.000Z - 23 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Aug 14, 2026, 1:45 PM EDT - 24 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 11:46 AM EDT - 24 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:11 AM EDT - 24 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Aug 14, 2026, 1:00 AM EDT - 24 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 7:24 AM EDT - 4 weeks ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 4 weeks ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 4 weeks ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Aug 4, 2026, 6:52 AM EDT - 4 weeks ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:45 AM EDT - 4 weeks ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Jul 30, 2026, 7:48 AM EDT - 5 weeks ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 5 weeks ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 6 weeks ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 6 weeks ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 6 weeks ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 7 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 1 month ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 2 months ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 2 months ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 2 months ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 2 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 3 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 3 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 3 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 3 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 3 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 3 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 3 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 3 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 3 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 3 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 3 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 3 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 3 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

truthseeeker Sep. 7 at 2:33 PM

0 · Reply

MollyJones567 Sep. 6 at 8:24 PM

$PFE volume really picking up here, way above the average pace today. Something's brewing under the surface. Bulls stepping in with size. Watching this one closely into the close.

0 · Reply

Noobnr1 Sep. 6 at 5:30 AM

$NYXH Hello we are so underrated, helping lots of people for a better sleep. Going to be a huge business, expanding well $GILD $PFE $OMER

0 · Reply

taxplanr Sep. 6 at 2:59 AM

13 year old football player dies at practice from cardiac arrest $MRNA $PFE $BNTX https://www.tiktok.com/t/ZTU6oeDBJ/

0 · Reply

IntiTheSunGod Sep. 5 at 8:04 PM

$IMRN will $PFE be the interested partner for IMM-529? Currently, they’re in phase 3 clinical trials with Vanderbilt University for another C. difficile medication

0 · Reply

EingeLTrade Sep. 5 at 6:07 PM

$PFE

0 · Reply

KimberleyAnn Sep. 5 at 11:57 AM

$MDCX $PFE mdcx, took a handful on this news; and watching walf’s calls over the summer have been pretty 🥵

0 · Reply

Agent8 Sep. 5 at 8:00 AM

0 · Reply

Duskfall Sep. 5 at 4:26 AM

$MDCX The current market capitalization of approximately $11 million is very low relative to what the company currently has in its pipeline. Keep👀📈✅ 🔥🔥🔥🔥🔥 $OCGN $PFE $MRNA $SPY

0 · Reply

walfofwallstreet Sep. 4 at 11:57 PM

$MDCX $1 billion deal with $PFE 💎 💯% candidate Tuesday 🤫

1 · Reply

walfofwallstreet Sep. 4 at 11:30 PM

$MDCX 💎🚨💰👀👀👀👀🐺 💎The weekend play💎💰🐺💰 Definitely can reach $1+ 💵 next week You can’t go wrong with $1 billion licensing deal with Pfizer $PFE 💎 finalised✅ New cancer drug💎Huge Tuesday💎

0 · Reply

CapitalMonk Sep. 4 at 10:50 PM

$PFE Price: $28.45 (-1.25%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.39% RSI: 65.7 | Momentum: Moderate Volume: -32.4% vs avg Volatility: 1.45% Support: $26.18 | Resistance: $29.21 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

LoneBroker Sep. 4 at 10:11 PM

$PFE $HPE $MSFT

0 · Reply

walfofwallstreet Sep. 4 at 8:15 PM

$MDCX $PFE Shorts are playing with fire 🔥 I’m loading more it’s gonna be huge over the weekend 💎🫵

1 · Reply

walfofwallstreet Sep. 4 at 8:09 PM

$MDCX 💎🚨💰👀👀👀👀🐺 💎The weekend play💎💰🐺💰 Can be top AH gainers today Definitely can reach $1+ 💵 next week You can’t go wrong with $1 billion licensing deal with Pfizer $PFE 💎 finalised✅ New cancer drug💎Huge Tuesday💎

0 · Reply

Duskfall Sep. 4 at 7:58 PM

$MDCX Exactly. $OCGN $PFE $MRNA $SPY

0 · Reply

walfofwallstreet Sep. 4 at 7:47 PM

$MDCX $1 billion deal with $PFE I am loaded over the weekend 💰🐺💰 Tuesday, everyone will be chasing 💎

0 · Reply

zustrelaax Sep. 4 at 7:47 PM

$PFE not an happy ending for this week , any news should move it to 35 ish and could be anytime

0 · Reply

walfofwallstreet Sep. 4 at 7:41 PM

$MDCX $1 billion deal with $PFE $MDCX Tuesday to the moon🚀🌑

0 · Reply

walfofwallstreet Sep. 4 at 7:37 PM

2 · Reply

Donald_J_Dumps Sep. 4 at 7:29 PM

$PFE I wish this turd would fall already so I could buy back in, this is the slowest moving stock.

0 · Reply

Micheal_Pothead Sep. 4 at 7:20 PM

$PFE market hates pharma today I guess

0 · Reply

Market Cap	162.16B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	9.33
Forward PE	9.55
Profit Margin	12.42%
Debt to Equity Ratio	0.74

Volume	23,791,900
Avg Vol	39,976,840
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	52%
Beta	0.34
Analysts	Sell
Price Target	$28.60